These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 2294993
1. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Gmür JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D, Metaxas M. Blood; 1990 Jan 01; 75(1):290-5. PubMed ID: 2294993 [Abstract] [Full Text] [Related]
3. [ABO-incompatible allogeneic bone marrow transplantation]. Xu L, Guo N, Wang S. Zhonghua Xue Ye Xue Za Zhi; 1999 Aug 01; 20(8):413-5. PubMed ID: 11721421 [Abstract] [Full Text] [Related]
4. Delayed erythropoiesis after major ABO-incompatible bone marrow transplantation: report of a case. Tang JL, Lin MT, Wang CH, Lin DT, Chen YC. J Formos Med Assoc; 1990 Oct 01; 89(10):892-5. PubMed ID: 1981778 [Abstract] [Full Text] [Related]
5. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Worel N, Greinix HT, Schneider B, Kurz M, Rabitsch W, Knöbl P, Reiter E, Derfler K, Fischer G, Hinterberger W, Höcker P, Kalhs P. Transfusion; 2000 May 01; 40(5):543-50. PubMed ID: 10827256 [Abstract] [Full Text] [Related]
6. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow. Bär BM, Van Dijk BA, Schattenberg A, de Man AJ, Kunst VA, de Witte T. Bone Marrow Transplant; 1995 Dec 01; 16(6):793-9. PubMed ID: 8750272 [Abstract] [Full Text] [Related]
7. ABO-incompatible bone marrow transplantation. Wiesneth M, Hertenstein B, Bunjes D, Schmeiser T, Maccari B, Northoff H, Laasch H, Heit W, Arnold R, Heimpel H. Beitr Infusionsther; 1992 Dec 01; 30():354-8. PubMed ID: 1284733 [Abstract] [Full Text] [Related]
8. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. Helbig G, Stella-Holowiecka B, Wojnar J, Krawczyk M, Krzemien S, Wojciechowska-Sadus M, Markiewicz M, Wylezol I, Kopera M, Holowiecki J. Ann Hematol; 2007 Sep 01; 86(9):677-83. PubMed ID: 17486341 [Abstract] [Full Text] [Related]
9. The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation. Araújo AB, Schmalfuss T, Furlan JM, Speransa D, Angeli MH, Sekine L, Franz JPM. Cytotherapy; 2024 Oct 01; 26(10):1179-1184. PubMed ID: 38795114 [Abstract] [Full Text] [Related]
10. Long duration of erythrocyte hypoplasia after bone marrow transplantation. Suzuki N, Kudoh T, Katoh S, Yohtoh Y, Miura J, Kamimura S, Sakuma Y, Fujita S, Chiba S. Acta Paediatr Jpn; 1992 Aug 01; 34(4):473-5. PubMed ID: 1414339 [Abstract] [Full Text] [Related]
11. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Santamaría A, Sureda A, Martino R, Domingo-Albós A, Muñiz-Díaz E, Brunet S. Bone Marrow Transplant; 1997 Dec 01; 20(12):1105-7. PubMed ID: 9466287 [Abstract] [Full Text] [Related]
12. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation. Ohta S, Yokoyama H, Ise T, Takasawa K, Wada T, Nakao S, Matsuda T, Kobayashi K. Intern Med; 1997 Jul 01; 36(7):487-91. PubMed ID: 9240498 [Abstract] [Full Text] [Related]
13. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch. De Santis GC, Garcia-Silva AC, Dotoli GM, de Castro PT, Simões BP, Covas DT. Clin Transplant; 2017 Apr 01; 31(4):. PubMed ID: 28160319 [Abstract] [Full Text] [Related]
14. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD. Xenotransplantation; 2006 Mar 01; 13(2):126-32. PubMed ID: 16623806 [Abstract] [Full Text] [Related]
15. [ABO-incompatible nonmyeloablative allogeneic peripheral blood stem cell transplantation]. Sun WJ, Guo M, Qiao JH, Yu CL, Wang DH, Sun QY, Zhang S, Li X, Ai HS. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb 01; 13(1):39-42. PubMed ID: 15748433 [Abstract] [Full Text] [Related]
16. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Scholl S, Klink A, Mügge LO, Schilling K, Höffken K, Sayer HG. Transfusion; 2005 Oct 01; 45(10):1676-83. PubMed ID: 16181220 [Abstract] [Full Text] [Related]
18. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Vox Sang; 1985 Oct 01; 48(2):89-104. PubMed ID: 2416122 [Abstract] [Full Text] [Related]